175 related articles for article (PubMed ID: 25050900)
1. Exome sequencing identifies a novel homozygous mutation in the phosphate transporter SLC34A1 in hypophosphatemia and nephrocalcinosis.
Rajagopal A; Braslavsky D; Lu JT; Kleppe S; Clément F; Cassinelli H; Liu DS; Liern JM; Vallejo G; Bergadá I; Gibbs RA; Campeau PM; Lee BH
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2451-6. PubMed ID: 25050900
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic infantile hypercalcemia: mutations in SLC34A1 and CYP24A1 in two siblings and fathers.
Güven A; Konrad M; Schlingmann KP
J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1353-1358. PubMed ID: 32866123
[TBL] [Abstract][Full Text] [Related]
3. Overlapping Phenotypes Associated With
Molin A; Lemoine S; Kaufmann M; Breton P; Nowoczyn M; Ballandonne C; Coudray N; Mittre H; Richard N; Ryckwaert A; Lavillaureix A; Jones G; Bacchetta J; Kottler ML
Front Endocrinol (Lausanne); 2021; 12():736240. PubMed ID: 34721296
[TBL] [Abstract][Full Text] [Related]
4. Rare Cause of Infantile Hypercalcemia: A Novel Mutation in the SLC34A1 Gene.
Kurnaz E; Savaş Erdeve Ş; Çetinkaya S; Aycan Z
Horm Res Paediatr; 2019; 91(4):278-284. PubMed ID: 30227399
[TBL] [Abstract][Full Text] [Related]
5. Digenic Heterozygous Mutations in SLC34A3 and SLC34A1 Cause Dominant Hypophosphatemic Rickets with Hypercalciuria.
Gordon RJ; Li D; Doyle D; Zaritsky J; Levine MA
J Clin Endocrinol Metab; 2020 Jul; 105(7):2392-400. PubMed ID: 32311027
[TBL] [Abstract][Full Text] [Related]
6. Prenatal hyperechogenic kidneys in three cases of infantile hypercalcemia associated with SLC34A1 mutations.
Hureaux M; Molin A; Jay N; Saliou AH; Spaggiari E; Salomon R; Benachi A; Vargas-Poussou R; Heidet L
Pediatr Nephrol; 2018 Oct; 33(10):1723-1729. PubMed ID: 29959532
[TBL] [Abstract][Full Text] [Related]
7. Biallelic and monoallelic pathogenic variants in CYP24A1 and SLC34A1 genes cause idiopathic infantile hypercalcemia.
Wang Q; Chen JJ; Wei LY; Ding Y; Liu M; Li WJ; Su C; Gong CX
Orphanet J Rare Dis; 2024 Mar; 19(1):126. PubMed ID: 38504242
[TBL] [Abstract][Full Text] [Related]
8. CYP24A1 and SLC34A1 genetic defects associated with idiopathic infantile hypercalcemia: from genotype to phenotype.
De Paolis E; Scaglione GL; De Bonis M; Minucci A; Capoluongo E
Clin Chem Lab Med; 2019 Oct; 57(11):1650-1667. PubMed ID: 31188746
[TBL] [Abstract][Full Text] [Related]
9. Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases.
Pronicka E; Ciara E; Halat P; Janiec A; Wójcik M; Rowińska E; Rokicki D; Płudowski P; Wojciechowska E; Wierzbicka A; Książyk JB; Jacoszek A; Konrad M; Schlingmann KP; Litwin M
J Appl Genet; 2017 Aug; 58(3):349-353. PubMed ID: 28470390
[TBL] [Abstract][Full Text] [Related]
10. Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia.
Schlingmann KP; Ruminska J; Kaufmann M; Dursun I; Patti M; Kranz B; Pronicka E; Ciara E; Akcay T; Bulus D; Cornelissen EA; Gawlik A; Sikora P; Patzer L; Galiano M; Boyadzhiev V; Dumic M; Vivante A; Kleta R; Dekel B; Levtchenko E; Bindels RJ; Rust S; Forster IC; Hernando N; Jones G; Wagner CA; Konrad M
J Am Soc Nephrol; 2016 Feb; 27(2):604-14. PubMed ID: 26047794
[TBL] [Abstract][Full Text] [Related]
11. Clinical Heterogeneity and Phenotypic Expansion of NaPi-IIa-Associated Disease.
Demir K; Yildiz M; Bahat H; Goldman M; Hassan N; Tzur S; Ofir A; Magen D
J Clin Endocrinol Metab; 2017 Dec; 102(12):4604-4614. PubMed ID: 29029121
[TBL] [Abstract][Full Text] [Related]
12. Infantile hypercalcemia with novel compound heterozygous mutation in SLC34A1 encoding renal sodium-phosphate cotransporter 2a: a case report.
Kang SJ; Lee R; Kim HS
Ann Pediatr Endocrinol Metab; 2019 Mar; 24(1):64-67. PubMed ID: 30943683
[TBL] [Abstract][Full Text] [Related]
13. CYP24A1 and SLC34A1 Pathogenic Variants Are Uncommon in a Canadian Cohort of Children with Hypercalcemia or Hypercalciuria.
Rousseau-Nepton I; Jones G; Schlingmann K; Kaufmann M; Zuijdwijk CS; Khatchadourian K; Gupta IR; Pacaud D; Pinsk MN; Mokashi A; Nour MA; Alexander RT; Rodd CJ
Horm Res Paediatr; 2021; 94(3-4):124-132. PubMed ID: 34320495
[TBL] [Abstract][Full Text] [Related]
14. A novel heterozygous mutation c.680A>G (p. N227S) in SLC34A1 gene leading to autosomal dominant hypophosphatemia: A case report.
Chen X; Xie Y; Wan S; Xu J; Cai B; Zhang Y; Yu X
Medicine (Baltimore); 2019 May; 98(20):e15617. PubMed ID: 31096470
[TBL] [Abstract][Full Text] [Related]
15. Mild Idiopathic Infantile Hypercalcemia-Part 1: Biochemical and Genetic Findings.
Lenherr-Taube N; Young EJ; Furman M; Elia Y; Assor E; Chitayat D; Uster T; Kirwin S; Robbins K; Vinette KMB; Daneman A; Marshall CR; Collins C; Thummel K; Sochett E; Levine MA
J Clin Endocrinol Metab; 2021 Sep; 106(10):2915-2937. PubMed ID: 34125233
[TBL] [Abstract][Full Text] [Related]
16. Sotos syndrome, infantile hypercalcemia, and nephrocalcinosis: a contiguous gene syndrome.
Kenny J; Lees MM; Drury S; Barnicoat A; Van't Hoff W; Palmer R; Morrogh D; Waters JJ; Lench NJ; Bockenhauer D
Pediatr Nephrol; 2011 Aug; 26(8):1331-4. PubMed ID: 21597970
[TBL] [Abstract][Full Text] [Related]
17. Characterization of two novel mutations in the claudin-16 and claudin-19 genes that cause familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
Perdomo-Ramirez A; Aguirre M; Davitaia T; Ariceta G; Ramos-Trujillo E; ; Claverie-Martin F
Gene; 2019 Mar; 689():227-234. PubMed ID: 30576809
[TBL] [Abstract][Full Text] [Related]
18. Renal phosphate handling and inherited disorders of phosphate reabsorption: an update.
Wagner CA; Rubio-Aliaga I; Hernando N
Pediatr Nephrol; 2019 Apr; 34(4):549-559. PubMed ID: 29275531
[TBL] [Abstract][Full Text] [Related]
19. Clinical, biochemical, and pathophysiological analysis of SLC34A1 mutations.
Fearn A; Allison B; Rice SJ; Edwards N; Halbritter J; Bourgeois S; Pastor-Arroyo EM; Hildebrandt F; Tasic V; Wagner CA; Hernando N; Sayer JA; Werner A
Physiol Rep; 2018 Jun; 6(12):e13715. PubMed ID: 29924459
[TBL] [Abstract][Full Text] [Related]
20. Loss of function of NaPiIIa causes nephrocalcinosis and possibly kidney insufficiency.
Dinour D; Davidovits M; Ganon L; Ruminska J; Forster IC; Hernando N; Eyal E; Holtzman EJ; Wagner CA
Pediatr Nephrol; 2016 Dec; 31(12):2289-2297. PubMed ID: 27378183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
